AstraZeneca
| AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
December 2022
Slide
32 of 42
Related slides by other companies
Nuvalent
Investor Presentation
February 2024
clinical development strategy for ongoing phase supports goal of moving up the treatment paradigm naive and treated ongoing global open label cohort phase with registrational intent enrollment planned across north and all patients receive at primary objective by blinded independent central review secondary objectives additional efficacy measures dor intracranial activity overall safety and tolerability confirmation of profile pros phase opportunity approval in both and cohort tumor type treatment status prior prior i positive naive none a positive treated any positive solid tumor any prior therapy none any registrational intent explorator cohort without | Nuvalent
Dare Bioscience
Investor Presentation
February 2023
advancing products women want late stage programs cream dare | Dare Bioscience
Apollomics
SPAC
September 2022
indications for near term submissions | Apollomics
Nuvalent
Investor Presentation
January 2024
clinical development strategy for ongoing phase supports goal of moving up the treatment paradigm naive and treated ongoing global open label cohort phase with registrational intent enrollment planned across north and all patients receive at primary objective by blinded independent central review secondary objectives additional efficacy measures dor intracranial activity overall safety and tolerability confirmation of profile pros phase opportunity approval in both and cohort tumor type treatment status prior prior i a positive naive none none positive treated any positive solid tumor any prior therapy registrational intent exploratory cohort an any line line benefit rate dor duration of response objective response rate overall survival progression free survival pro patient reported outcomes once daily tyrosine kinase inhibitor time to response approximate cohort size subject to change either or platinum based chemotherapy with or without with initial of either or includes who do not qualify any of the other cohorts | Nuvalent
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights